title: Is donor age a risk factor for poor graft function after orthotopic liver transplantation?
authors.affiliation: Department of Surgery, University of Rome Tor Vergata, Ospedale S. Eugenio, Italy.
authors.forename: G
authors.initials: G
authors.lastname: Tisone
authors.forename: J
authors.initials: J
authors.lastname: Romagnoli
authors.forename: G
authors.initials: G
authors.lastname: Vennarecci
authors.forename: A
authors.initials: A
authors.lastname: Anselmo
authors.forename: M
authors.initials: M
authors.lastname: Angelico
authors.forename: C
authors.initials: C
authors.lastname: Gandin
authors.forename: M
authors.initials: M
authors.lastname: Dauri
authors.forename: C U
authors.initials: CU
authors.lastname: Casciani
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006085:Graft Survival; D006501:Hepatic Encephalopathy / Q000601:surgery; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015994:Incidence; D016031:Liver Transplantation / Q000502:physiology*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology*; D012189:Retrospective Studies; D014019:Tissue Donors / Q000145:classification*
chemical_list: D007166:Immunosuppressive Agents